Karyopharm Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2017
Total Assets: $180.3M
Liabilities Breakdown FY2017
Total Liabilities: $50.8M
Asset Breakdown
Total Assets: $180.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $69.0M | 38.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.2M | 1.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $109.1M | 60.5% |
Liabilities Breakdown
Total Liabilities: $50.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.7M | 11.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $45.2M | 88.9% |